Back to Journals » Clinical Ophthalmology » Volume 6

Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?

Authors Tsolaki F, GOGAKI E, Filippos Sakkias, Skatharoudi C, Chryssanthi Lopatatzidi, Vassilios Tsoulopoulos, Stefania Lampoura, Fotios Topouzis, Tsolaki M, John Kountouras

Received 1 October 2011

Accepted for publication 13 November 2011

Published 6 January 2012 Volume 2012:6 Pages 45—47


Review by Single anonymous peer review

Peer reviewer comments 5

Fani Tsolaki1, Eleni Gogaki1, Filippos Sakkias1, Christina Skatharoudi1, Chrysanthi Lopatatzidi1, Vassilios Tsoulopoulos1, Stefania Lampoura1, Fotios Topouzis2, Magdalini Tsolaki3, Jannis Kountouras4
Ophthalmology Department, Hippokrateion Hospital of Thessaloniki, Thessaloniki, Greece; 2Ophthalmology Department, 3Department of Neurology, 4Gastroenterology Department, Aristotle University of Thessaloniki, Hippokrateion Hospital, Thessaloniki, Greece

Abstract: Glaucoma, the most common form of which is primary open-angle glaucoma (POAG), is a neurodegenerative disease which is the second most common cause of blindness worldwide. Among the factors that have been implicated in the pathophysiology of this disease is infection with Helicobacter pylori. This alleged association has caused a great deal of scientific discussion during the past decade, as the establishment of such a correlation might lead to therapeutic applications for all glaucoma patients. In this review, we assess all relevant major studies and trials in an effort to elucidate the issue.

Keywords: Helicobacter pylori, primary open-angle glaucoma, apoptosis
A Letter to the Editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]